Advertisements



Divi"s stock: Pricing pressure for drug makers can lead to more outsourcing

Analysts at Motilal Oswal Securities expect Divi's earnings before interest, tax, depreciation and amortisation (Ebitda) margin to improve by 400 basis points to 36 per cent.....»»

Category: topSource: business-standardApr 16th, 2018

Altria: New Products and Improved Structure Could Lead to a Successful Turnaround

The outlook for Altria may be significantly more positive than the stock market is pricing inRelated Stocks: MO,.....»»

Category: blogSource: gurufocusJun 25th, 2018

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

InvestorPlace - Stock Market News, Stock Advice & Trading T.....»»

Category: topSource: investorplaceMay 19th, 2018

Infinera stock falls after company warns of pricing pressure, but analysts maintain bullish stances

Shares of Infinera Corp. are down 8.2% in premarket trading Thursday after the optical transmission equipment maker reported better-than-expected quarterly results but spoke of pricing pressure fr.....»»

Category: topSource: marketwatchMay 10th, 2018

Generic drug makers under pressure following Aceto, Novartis news

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2018

Outsourcing Industry Stock Outlook: Near-Term Prospects Take a Hit

Zacks.....»»

Category: topSource: redinewsJul 14th, 2018

FDA recalls heart drugs made by Teva, others over carcinogen impurity

The Food and Drug Administration issued a voluntary recall late Friday of high-blood pressure and heart drugs contain.....»»

Category: topSource: marketwatchJul 13th, 2018

Outsourcing Industry Stock Outlook: Near-Term Prospects Take a Hit

Outsourcing Industry Stock Outlook: Near-Term Prospects Take a Hit The global outsourcing services industry has been unstable over the past few years. A report from statista shows th.....»»

Category: worldSource: nytJul 13th, 2018

Here"s Why Puma Biotechnology Rose 11.7% in June

The biotech had a reverse of fortune for its lead drug in Europe.....»»

Category: topSource: foxnewsJul 13th, 2018

Novartis had ‘longer and more detailed’ relationship with Trump lawyer Michael Cohen, Senate report finds

Novartis’ then-CEO sent ideas to lower drug prices to Michael Cohen — proposals that later appeared in President Donald Trump’s drug pricing plan......»»

Category: topSource: marketwatchJul 13th, 2018

Aptiv Sees Hammer Chart Pattern: Time to Buy?

Aptiv Sees Hammer Chart Pattern: Time to Buy? Aptiv PLC APTV has been struggling lately, but the selling pressure may be coming to an end soon. That is because APTV recently saw a Hammer Chart Pattern which can signal that the stock is .....»»

Category: smallbizSource: nytJul 13th, 2018

Weak Sales at Victoria"s Secret Lead to Drop in L Brands (LB) Stock

Zacks.....»»

Category: topSource: redinewsJul 12th, 2018

Zogenix stock soars on anti-seizure drug results

Zogenix (ZGNX) stock surged more than 17% Thursday as the company's seizure drug helped to reduce seizures during its latest clinical trial......»»

Category: topSource: moneycentralJul 12th, 2018

Why Johnson & Johnson stock has lost 13% this year

Uncertainty over drug prices has investors looking past strong sales growth......»»

Category: topSource: moneycentralJul 12th, 2018

Zogenix (ZGNX) Stock Soars on Anti-Seizure Drug Results

InvestorPlace - Stock Market News, Stock Advi.....»»

Category: topSource: investorplaceJul 12th, 2018

Weak Sales at Victoria"s Secret Lead to Drop in L Brands (LB) Stock

After L Brands (LB) announced weak sales for the month o.....»»

Category: personnelSource: nytJul 12th, 2018

Why Johnson & Johnson Stock Has Lost 13% This Year

Uncertainty over drug prices has investors looking past strong sales growth......»»

Category: topSource: moneycentralJul 12th, 2018

Zogenix Stock Soars on Anti-Seizure Drug Results

Zogenix (ZGNX) stock surged more than 17% Thursday as the company's seizure drug helped to reduce seizures during its latest clinical trial......»»

Category: topSource: moneycentralJul 12th, 2018

Technology companies lead US stock indexes higher

U.S. stocks are rising in early trading Thursday as technology companies like Apple resume their upward march......»»

Category: topSource: foxnewsJul 12th, 2018

GMS Sees Hammer Chart Pattern: Time to Buy?

GMS Sees Hammer Chart Pattern: Time to Buy? GMS Inc. GMS has been struggling lately, but the selling pressure may be coming to an end soon. That is because GMS recently saw a Hammer Chart Pattern which can signal that the stock is near.....»»

Category: personnelSource: nytJul 12th, 2018

Taiwan makers under pressure from China restrictions on PV installation

China's latest move to impose stricter control on PV installations has sent a chilling wave across the domestic market, and in turn created pressure on Taiwan-based solar power supply chain......»»

Category: topSource: digitimesJul 12th, 2018